Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature

Author(s): Jimmy T. Efird*, Ethan J. Anderson, Charulata Jindal and Ayako Suzuki

Volume 28, Issue 21, 2022

Published on: 23 May, 2022

Page: [1695 - 1702] Pages: 8

DOI: 10.2174/1381612828666220418132847

Abstract

Vitamin D is an important immune-modulator with anti-inflammatory properties. While this prohormone has been studied extensively in the prevention and treatment of COVID-19, findings have been inconsistent regarding its overall benefit in patients hospitalized with COVID-19. Most studies to date have been observational in nature, not accounting for the use of corticosteroids. Furthermore, the few randomized clinical trials designed to examine the effect of vitamin D supplementation on COVID-19 outcomes have been relatively small and thus insufficiently powered to assure a balance of corticosteroid use between study arms. The current perspective addresses the interaction of vitamin D and corticosteroids as a potential explanation for the divergent results reported in the literature. Future research on vitamin D and COVID-19 will benefit by considering this interaction, especially among hospitalized patients requiring oxygen and mechanical ventilation.

Keywords: Anti-inflammatory, corticosteroids, COVID-19, cytokine storm, SARS-CoV-2, vitamin D.

Next »
[1]
Mandal AK, Wenban C, Heer RS, Baktash V, Missouris CG. Does Vitamin D have a role to play in COVID-19 in the dexamethasone era? Diabetes Metab Syndr 2021; 15(5): 102237.
[http://dx.doi.org/10.1016/j.dsx.2021.102237 ] [PMID: 34364302]
[2]
Hahn DL. Glucocorticosteroids are potential confounders in studies of vitamin D and asthma. Am J Respir Crit Care Med 2012; 185(11): 1245.
[http://dx.doi.org/10.1164/ajrccm.185.11.1245 ] [PMID: 22661526]
[3]
Litonjua AA. Vitamin D and corticosteroids in asthma: Synergy, interaction and potential therapeutic effects. Expert Rev Respir Med 2013; 7(2): 101-4.
[http://dx.doi.org/10.1586/ers.12.85 ] [PMID: 23547985]
[4]
Demer LL, Hsu JJ, Tintut Y. Steroid hormone vitamin D: Implications for cardiovascular disease. Circ Res 2018; 122(11): 1576-85.
[http://dx.doi.org/10.1161/CIRCRESAHA.118.311585 ] [PMID: 29798901]
[5]
Korf H, Decallonne B, Mathieu C. Vitamin D for infections. Curr Opin Endocrinol Diabetes Obes 2014; 21(6): 431-6.
[http://dx.doi.org/10.1097/MED.0000000000000108 ] [PMID: 25354043]
[6]
Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 2020; 15(9): e0239252.
[http://dx.doi.org/10.1371/journal.pone.0239252 ] [PMID: 32941512]
[7]
Faniyi AA, Lugg ST, Faustini SE, et al. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers. Eur Respir J 2021; 57(4): 2004234.
[http://dx.doi.org/10.1183/13993003.04234-2020 ] [PMID: 33303541]
[8]
D’Avolio A, Avataneo V, Manca A, et al. 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 2020; 12(5): E1359.
[http://dx.doi.org/10.3390/nu12051359 ] [PMID: 32397511]
[9]
Merzon E, Tworowski D, Gorohovski A, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: An Israeli population-based study. FEBS J 2020; 287(17): 3693-702.
[http://dx.doi.org/10.1111/febs.15495 ] [PMID: 32700398]
[10]
Munshi R, Hussein MH, Toraih EA, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol 2021; 93(2): 733-40.
[http://dx.doi.org/10.1002/jmv.26360 ] [PMID: 32716073]
[11]
Luo X, Liao Q, Shen Y, Li H, Cheng L. Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. J Nutr 2021; 151(1): 98-103.
[http://dx.doi.org/10.1093/jn/nxaa332 ] [PMID: 33188401]
[12]
Tehrani S, Khabiri N, Moradi H, Mosavat MS, Khabiri SS. Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality. Clin Nutr ESPEN 2021; 42: 313-7.
[http://dx.doi.org/10.1016/j.clnesp.2021.01.014 ] [PMID: 33745598]
[13]
Reis BZ, Fernandes AL, Sales LP, et al. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: A multicenter prospective cohort study. Am J Clin Nutr 2021; 114(2): 598-604.
[http://dx.doi.org/10.1093/ajcn/nqab151 ] [PMID: 34020451]
[14]
Dramé M, Cofais C, Hentzien M, et al. Relation between vitamin D and COVID-19 in aged people: A systematic review. Nutrients 2021; 13(4): 1339.
[http://dx.doi.org/10.3390/nu13041339 ] [PMID: 33920639]
[15]
Cereda E, Bogliolo L, Klersy C, et al. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr 2021; 40(4): 2469-72.
[http://dx.doi.org/10.1016/j.clnu.2020.10.055 ] [PMID: 33187772]
[16]
Cereda E, Bogliolo L, Lobascio F, et al. Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy. Nutrition 2021; 82: 111055.
[http://dx.doi.org/10.1016/j.nut.2020.111055 ] [PMID: 33288411]
[17]
Campi I, Gennari L, Merlotti D, et al. Vitamin D and COVID-19 severity and related mortality: A prospective study in Italy. BMC Infect Dis 2021; 21(1): 566.
[http://dx.doi.org/10.1186/s12879-021-06281-7 ] [PMID: 34126960]
[18]
Mariani J, Giménez VMM, Bergam I, et al. Association between vitamin D deficiency and COVID-19 incidence, complications, and mortality in 46 Countries: An ecological study. Health Secur 2021; 19(3): 302-8.
[http://dx.doi.org/10.1089/hs.2020.0137 ] [PMID: 33325788]
[19]
Baktash V, Hosack T, Patel N, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 2021; 97(1149): 442-7.
[PMID: 32855214]
[20]
Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 2020; 12(9): E2757.
[http://dx.doi.org/10.3390/nu12092757 ] [PMID: 32927735]
[21]
Bianconi V, Mannarino MR, Figorilli F, et al. Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19. Nutrition 2021; 91-92: 111408.
[http://dx.doi.org/10.1016/j.nut.2021.111408 ] [PMID: 34388589]
[22]
Pecina JL, Merry SP, Park JG, Thacher TD. Vitamin D status and severe COVID-19 disease outcomes in hospitalized patients. J Prim Care Community Health 2021; 12: 21501327211041206.
[http://dx.doi.org/10.1177/21501327211041206 ] [PMID: 34452582]
[23]
Butler-Laporte G, Nakanishi T, Mooser V, et al. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 host genetics initiative: A Mendelian randomization study. PLoS Med 2021; 18(6): e1003605.
[http://dx.doi.org/10.1371/journal.pmed.1003605 ] [PMID: 34061844]
[24]
Soliman AR, Abdelaziz TS, Fathy A. Impact of vitamin D therapy on the progress COVID-19: Six weeks follow-up study of vitamin D deficient elderly diabetes patients. Proc Singapore Healthc 2021.
[25]
Rawat D, Roy A, Maitra S, Shankar V, Khanna P, Baidya DK. Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis. Diabetes Metab Syndr 2021; 15(4): 102189.
[http://dx.doi.org/10.1016/j.dsx.2021.102189 ] [PMID: 34217144]
[26]
Pimentel GD, Dela Vega MCM, Pichard C. Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19. Clin Nutr ESPEN 2021; 44: 466-8.
[http://dx.doi.org/10.1016/j.clnesp.2021.05.021 ] [PMID: 34330507]
[27]
Abraham J, Dowling K, Florentine S. Can optimum solar radiation exposure or supplemented vitamin D intake reduce the severity of COVID-19 symptoms? Int J Environ Res Public Health 2021; 18(2): E740.
[http://dx.doi.org/10.3390/ijerph18020740 ] [PMID: 33467131]
[28]
Bui L, Zhu Z, Hawkins S, Cortez-Resendiz A, Bellon A. Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Med 2021; 9: 20503121211014073.
[http://dx.doi.org/10.1177/20503121211014073 ] [PMID: 34046177]
[29]
Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, et al. Calcifediol treatment and hospital mortality due to COVID-19: A cohort study. Nutrients 2021; 13(6): 1760.
[http://dx.doi.org/10.3390/nu13061760 ] [PMID: 34064175]
[30]
Griffin G, Hewison M, Hopkin J, et al. Vitamin D and COVID-19: evidence and recommendations for supplementation. R Soc Open Sci 2020; 7(12): 201912.
[http://dx.doi.org/10.1098/rsos.201912 ] [PMID: 33489300]
[31]
Dror AA, Morozov N, Daoud A, et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. medRxiv 2021; 2021.06.04.21258358.
[http://dx.doi.org/10.1101/2021.06.04.21258358]
[32]
Lakkireddy M, Gadiga SG, Malathi RD, et al. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 2021; 11(1): 10641.
[http://dx.doi.org/10.1038/s41598-021-90189-4 ] [PMID: 34017029]
[33]
Jude EB, Ling SF, Allcock R, Yeap BXY, Pappachan JM. Vitamin D deficiency is associated with higher hospitalization risk from COVID-19: A retrospective case-control study. J Clin Endocrinol Metab 2021; 106(11): e4708-15.
[http://dx.doi.org/10.1210/clinem/dgab439 ] [PMID: 34139758]
[34]
Jungreis I, Kellis M. Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.11.08.20222638]
[35]
Davoudi A, Najafi N, Aarabi M, et al. Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection. BMC Infect Dis 2021; 21(1): 450.
[http://dx.doi.org/10.1186/s12879-021-06168-7 ] [PMID: 34006228]
[36]
Lordan R. Notable developments for Vitamin D amid the COVID-19 pandemic, but caution warranted overall: A narrative review. Nutrients 2021; 13(3): 740.
[http://dx.doi.org/10.3390/nu13030740 ] [PMID: 33652653]
[37]
Papadimitriou DT, Vassaras AK, Holick MF. Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach. World J Virol 2021; 10(3): 111-29.
[http://dx.doi.org/10.5501/wjv.v10.i3.111 ] [PMID: 34079693]
[38]
Arroyo-Díaz JA, Julve J, Vlacho B, et al. Previous vitamin D supplementation and morbidity and mortality outcomes in people hospitalised for COVID19: A cross-sectional study. Front Public Health 2021; 9: 758347.
[http://dx.doi.org/10.3389/fpubh.2021.758347 ] [PMID: 34631653]
[39]
Mercola J, Grant WB, Wagner CL. Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 2020; 12(11): E3361.
[http://dx.doi.org/10.3390/nu12113361 ] [PMID: 33142828]
[40]
Haug EG, D.d. Lalouviere, Isharc L. Vitamin D and COVID-19 is there a lack of risk reward understanding among health authorities 2020; 1-16. Available from: https://www.researchgate.net/publication/346423180
[41]
Cui Z, Tian Y. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: A Mendelian randomization study. J Transl Med 2021; 19(1): 300.
[http://dx.doi.org/10.1186/s12967-021-02973-5 ] [PMID: 34246301]
[42]
AlSafar H, Grant WB, Hijazi R, et al. COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents. Nutrients 2021; 13(5): 1714.
[http://dx.doi.org/10.3390/nu13051714 ] [PMID: 34069412]
[43]
Diaz-Curiel M, Cabello A, Arboiro-Pinel R, et al. The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients. J Steroid Biochem Mol Biol 2021; 212: 105928.
[http://dx.doi.org/10.1016/j.jsbmb.2021.105928 ] [PMID: 34091026]
[44]
Mazess RB, Bischoff-Ferrari HA, Dawson-Hughes B, Vitamin D. Bolus is bogus—a narrative review. JBMR Plus 2021; 5(12): e10567.
[PMID: 34950828]
[45]
Chen J, Mei K, Xie L, et al. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: A meta-analysis and GRADE assessment of cohort studies and RCTs. Nutr J 2021; 20(1): 89.
[http://dx.doi.org/10.1186/s12937-021-00744-y ] [PMID: 34719404]
[46]
Osman W, Al Fahdi F, Al Salmi I, Al Khalili H, Gokhale A, Khamis F. Serum calcium and vitamin D levels: Correlation with severity of COVID-19 in hospitalized patients in royal hospital, Oman. Int J Infect Dis 2021; 107: 153-63.
[http://dx.doi.org/10.1016/j.ijid.2021.04.050 ] [PMID: 33892191]
[47]
D’Avolio A, Isaia G. Vitamin D in the COVID-19 prevention and treatment: Emerging evidence. 2021; 3(2): 350-6.
[http://dx.doi.org/10.36118/pharmadvances.2021.01]
[48]
Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CCT, Babajafari S. Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: A systematic review and meta-analysis. Adv Nutr 2021; 12(5): 1636-58.
[http://dx.doi.org/10.1093/advances/nmab012 ] [PMID: 33751020]
[49]
Ricci A, Pagliuca A, D’Ascanio M, et al. Circulating vitamin D levels status and clinical prognostic indices in COVID-19 patients. Respir Res 2021; 22(1): 76.
[http://dx.doi.org/10.1186/s12931-021-01666-3 ] [PMID: 33658032]
[50]
Verdoia M, De Luca G. Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic. QJM 2021; 114(1): 3-10.
[http://dx.doi.org/10.1093/qjmed/hcaa234 ] [PMID: 32735326]
[51]
Lanham-New SA, Webb AR, Cashman KD, et al. Vitamin D and SARS-CoV-2 virus/COVID-19 disease. BMJ Nutr Prev Health 2020; 3(1): 106-10.
[http://dx.doi.org/10.1136/bmjnph-2020-000089 ] [PMID: 33230499]
[52]
Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: Low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther 2020; 51(12): 1434-7.
[http://dx.doi.org/10.1111/apt.15777 ] [PMID: 32311755]
[53]
Rhodes J, Dunstan F, Laird E, Subramanian S, Kenny RA. COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D. BMJ Nutr Prev Health 2020; 3(1): 118-20.
[PMID: 33235975]
[54]
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 2020; 203: 105751.
[http://dx.doi.org/10.1016/j.jsbmb.2020.105751 ] [PMID: 32871238]
[55]
Fasano A, Cereda E, Barichella M, et al. COVID-19 in Parkinson’s disease patients living in Lombardy, Italy. Mov Disord 2020; 35(7): 1089-93.
[http://dx.doi.org/10.1002/mds.28176 ] [PMID: 32484584]
[56]
Tan CW, Ho LP, Kalimuddin S, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 2020; 79-80: 111017.
[http://dx.doi.org/10.1016/j.nut.2020.111017 ] [PMID: 33039952]
[57]
Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R. Vitamin D supplementation in COVID-19 patients: A clinical case series. Am J Ther 2020; 27(5): e485-90.
[http://dx.doi.org/10.1097/MJT.0000000000001222 ] [PMID: 32804682]
[58]
Annweiler C, Hanotte B, Grandin de l’Eprevier C, Sabatier JM, Lafaie L, Célarier T. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. J Steroid Biochem Mol Biol 2020; 204: 105771.
[http://dx.doi.org/10.1016/j.jsbmb.2020.105771 ] [PMID: 33065275]
[59]
Eskin MNA, Vitamin D. Int J Food Sci Nutr Diet 2021; 10(01e): 1-2.
[http://dx.doi.org/10.19070/2326-3350-2100011e]
[60]
Brenner H, Vitamin D, Vitamin D. Supplementation to prevent COVID-19 infections and deaths-accumulating evidence from epidemiological and intervention studies calls for immediate action. Nutrients 2021; 13(2): 411.
[http://dx.doi.org/10.3390/nu13020411 ] [PMID: 33525447]
[61]
Raisi-Estabragh Z, Martineau AR, Curtis EM, et al. Vitamin D and coronavirus disease 2019 (COVID-19): Rapid evidence review. Aging Clin Exp Res 2021; 33(7): 2031-41.
[http://dx.doi.org/10.1007/s40520-021-01894-z ] [PMID: 34118024]
[62]
Annweiler G, Corvaisier M, Gautier J, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID quasi-experimental study. Nutrients 2020; 12(11): E3377.
[http://dx.doi.org/10.3390/nu12113377 ] [PMID: 33147894]
[63]
Ling SF, Broad E, Murphy R, et al. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: A cross-sectional multi-centre observational study. Nutrients 2020; 12(12): E3799.
[http://dx.doi.org/10.3390/nu12123799 ] [PMID: 33322317]
[64]
Rastogi A, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study). Postgrad Med J 2020.
[http://dx.doi.org/10.1136/postgradmedj-2020-139065 ] [PMID: 33184146]
[65]
Alguwaihes AM, Sabico S, Hasanato R, et al. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: A retrospective case-control study in an Arab Gulf country. Aging Clin Exp Res 2021; 33(5): 1415-22.
[http://dx.doi.org/10.1007/s40520-021-01831-0 ] [PMID: 33788172]
[66]
Carpagnano GE, Di Lecce V, Quaranta VN, et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest 2021; 44(4): 765-71.
[http://dx.doi.org/10.1007/s40618-020-01370-x ] [PMID: 32772324]
[67]
Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 2020; 10(1): 20191.
[http://dx.doi.org/10.1038/s41598-020-77093-z ] [PMID: 33214648]
[68]
Macaya F, Espejo Paeres C, Valls A, et al. Interaction between age and vitamin D deficiency in severe COVID-19 infection. Nutr Hosp 2020; 37(5): 1039-42.
[http://dx.doi.org/10.20960/nh.03193 ] [PMID: 32960622]
[69]
Giannini S, Passeri G, Tripepi G, et al. Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: A hypothesis-generating study. Nutrients 2021; 13(1): 219.
[http://dx.doi.org/10.3390/nu13010219 ] [PMID: 33466642]
[70]
Cangiano B, Fatti LM, Danesi L, et al. Mortality in an Italian nursing home during COVID-19 pandemic: Correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests. Aging (Albany NY) 2020; 12(24): 24522-34.
[http://dx.doi.org/10.18632/aging.202307 ] [PMID: 33353888]
[71]
Vasheghani M, Jannati N, Baghaei P, Rezaei M, Aliyari R, Marjani M. The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality. Sci Rep 2021; 11(1): 17594.
[http://dx.doi.org/10.1038/s41598-021-97017-9 ] [PMID: 34475485]
[72]
Mendy A, Apewokin S, Wells AA, Morrow AL. Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.06.25.20137323]
[73]
Panagiotou G, Tee SA, Ihsan Y, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf) 2020; 93(4): 508-11.
[http://dx.doi.org/10.1111/cen.14276 ] [PMID: 32621392]
[74]
Ye K, Tang F, Shaw BA, et al. Does serum vitamin D level affect COVID-19 infection and its severity?-A case-control study. J Am Coll Nutr 2021; 40(8): 724-31.
[PMID: 33048028]
[75]
Barassi A, Pezzilli R, Mondoni M, et al. Vitamin D in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support. Panminerva Med 2021. Online ahead of print
[http://dx.doi.org/10.23736/S0031-0808.21.04277-4 ] [PMID: 33494567]
[76]
Jevalikar G, Mithal A, Singh A, et al. Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep 2021; 11(1): 6258.
[http://dx.doi.org/10.1038/s41598-021-85809-y ] [PMID: 33737631]
[77]
Szeto B, Zucker JE, LaSota ED, et al. Vitamin D status and COVID-19 clinical outcomes in hospitalized patients. Endocr Res 2021; 46(2): 66-73.
[http://dx.doi.org/10.1080/07435800.2020.1867162 ] [PMID: 33380209]
[78]
Hernández JL, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab 2021; 106(3): e1343-53.
[http://dx.doi.org/10.1210/clinem/dgaa733]
[79]
Lohia P, Nguyen P, Patel N, Kapur S. Exploring the link between vitamin D and clinical outcomes in COVID-19. Am J Physiol Endocrinol Metab 2021; 320(3): E520-6.
[http://dx.doi.org/10.1152/ajpendo.00517.2020 ] [PMID: 33404354]
[80]
Güven M, Gültekin H. The effect of high-dose parenteral vitamin D3 on COVID-19-related in hospital mortality in critical COVID-19 patients during intensive care unit admission: An observational cohort study. Eur J Clin Nutr 2021; 75(9): 1383-8.
[http://dx.doi.org/10.1038/s41430-021-00984-5 ] [PMID: 34302132]
[81]
Reijven PLM, Soeters PB, Vitamin D. A magic bullet or a myth? Clin Nutr 2020; 39(9): 2663-74.
[http://dx.doi.org/10.1016/j.clnu.2019.12.028 ] [PMID: 31959477]
[82]
Speeckaert MM, Speeckaert R, Delanghe JR, Vitamin D. Vitamin D sufficiency and COVID-19: Is vitamin D binding protein (and its polymorphism) the missing link? Endocr Pract 2021; 27(6): 645.
[http://dx.doi.org/10.1016/j.eprac.2021.03.011 ] [PMID: 33819636]
[83]
Charoenngam N, Shirvani A, Reddy N, Vodopivec DM, Apovian CM, Holick MF. Authors’ reply: Vitamin D sufficiency and COVID-19: Is vitamin D binding protein (and its polymorphism) the missing link? Endocr Pract 2021; 27(6): 646-7.
[http://dx.doi.org/10.1016/j.eprac.2021.03.016 ] [PMID: 33819635]
[84]
Borsche L, Glauner B, von Mendel J. COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25(OH)D3: Results of a systematic review and meta-analysis. medRxiv 2021.
[http://dx.doi.org/10.1101/2021.09.22.21263977]
[85]
Libon F, Cavalier E, Nikkels AF. Skin color is relevant to vitamin D synthesis. Dermatology 2013; 227(3): 250-4.
[http://dx.doi.org/10.1159/000354750 ] [PMID: 24134867]
[86]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553 ] [PMID: 17634462]
[87]
Parva NR, Tadepalli S, Singh P, et al. Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012). Cureus 2018; 10(6): e2741.
[http://dx.doi.org/10.7759/cureus.2741 ] [PMID: 30087817]
[88]
Benskin LL. The influence of vitamin D on Covid-19 outcomes, in Covid-19 and nutraceuticals: A guidebook.
[http://dx.doi.org/10.13140/RG.2.2.30651.95520]
[89]
Meltzer DO, Best TJ, Zhang H, Vokes T, Arora VM, Solway J. Association of vitamin D levels, race/ethnicity, and clinical characteristics with COVID-19 test results. JAMA Netw Open 2021; 4(3): e214117.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.4117 ] [PMID: 33739433]
[90]
Akbari AR, Khan M, Adeboye W, Hai Lee LH, Chowdhury SI. Ethnicity as a risk factor for vitamin D deficiency and undesirable COVID-19 outcomes. Rev Med Virol 2021; e2291. Online ahead of print
[http://dx.doi.org/10.1002/rmv.2291 ] [PMID: 34516034]
[91]
Sze S, Pan D, Nevill CR, et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2020; 29: 100630.
[http://dx.doi.org/10.1016/j.eclinm.2020.100630 ] [PMID: 33200120]
[92]
Hollis ND, Li W, Van Dyke ME, et al. Racial and ethnic disparities in incidence of SARS-CoV-2 infection, 22 US States and DC, January 1-October 1, 2020. Emerg Infect Dis 2021; 27(5): 1477-81.
[http://dx.doi.org/10.3201/eid2705.204523 ] [PMID: 33900192]
[93]
Pan D, Martin CA, Nazareth J, et al. Ethnic disparities in COVID-19: Increased risk of infection or severe disease? Lancet 2021; 398(10298): 389-90.
[http://dx.doi.org/10.1016/S0140-6736(21)01428-8 ] [PMID: 34332680]
[94]
McPadden J, Warner F, Young HP, et al. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLoS One 2021; 16(3): e0243291.
[http://dx.doi.org/10.1371/journal.pone.0243291 ] [PMID: 33788846]
[95]
Ayoubkhani D, Nafilyan V, White C, et al. Ethnic-minority groups in England and Wales-factors associated with the size and timing of elevated COVID-19 mortality: A retrospective cohort study linking census and death records. Int J Epidemiol 2021; 49(6): 1951-62.
[http://dx.doi.org/10.1093/ije/dyaa208 ] [PMID: 33349855]
[96]
Aldridge RW, Lewer D, Katikireddi SV, et al. Black, Asian and minority ethnic groups in England are at increased risk of death from COVID-19: Indirect standardisation of NHS mortality data. Wellcome Open Res 2020; 5: 88.
[http://dx.doi.org/10.12688/wellcomeopenres.15922.2 ] [PMID: 32613083]
[97]
Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: An observational cohort study using the OpenSAFELY platform. Lancet 2021; 397(10286): 1711-24.
[http://dx.doi.org/10.1016/S0140-6736(21)00634-6 ] [PMID: 33939953]
[98]
Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19: Authors reply. Lancet 2021; 398(10298): 390.
[http://dx.doi.org/10.1016/S0140-6736(21)01424-0 ] [PMID: 34332682]
[99]
de Lusignan S, Joy M, Oke J, et al. Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network. J Infect 2020; 81(5): 785-92.
[http://dx.doi.org/10.1016/j.jinf.2020.08.037 ] [PMID: 32858068]
[100]
Pearce N, Rhodes S, Stocking K, et al. Occupational differences in COVID-19 incidence, severity, and mortality in the United Kingdom: Available data and framework for analyses. Wellcome Open Res 2021; 6: 102.
[http://dx.doi.org/10.12688/wellcomeopenres.16729.1 ] [PMID: 34141900]
[101]
Pan D, Sze S, Nevill CR, Nellums LB, Pareek M. Authors’ reply: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2020; 31: 100686.
[http://dx.doi.org/10.1016/j.eclinm.2020.100686 ] [PMID: 33409481]
[102]
Chadeau-Hyam M, Bodinier B, Elliott J, et al. Risk factors for positive and negative COVID-19 tests: A cautious and in-depth analysis of UK biobank data. Int J Epidemiol 2020; 49(5): 1454-67.
[http://dx.doi.org/10.1093/ije/dyaa134 ] [PMID: 32814959]
[103]
MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76(4): 1536-8.
[http://dx.doi.org/10.1172/JCI112134 ] [PMID: 2997282]
[104]
Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev 2020; 53: 33-7.
[http://dx.doi.org/10.1016/j.cytogfr.2020.04.005 ] [PMID: 32389499]
[105]
Suzuki A, Efird JT, Redding TS IV, et al. COVID-19-associated mortality in US veterans with and without SARS-CoV-2 infection. Int J Environ Res Public Health 2021; 18(16): 8486.
[http://dx.doi.org/10.3390/ijerph18168486 ] [PMID: 34444232]
[106]
Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab 2011; 96(12): 3838-45.
[http://dx.doi.org/10.1210/jc.2011-1600 ] [PMID: 21956424]
[107]
Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 2010; 125(5): 995-1000.
[http://dx.doi.org/10.1016/j.jaci.2010.03.008 ] [PMID: 20381849]
[108]
Davidson ZE, Walker KZ, Truby H. Clinical review: Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 2012; 97(3): 738-44.
[http://dx.doi.org/10.1210/jc.2011-2757 ] [PMID: 22188740]
[109]
Zoorob RJ, Cender D. A different look at corticosteroids. Am Fam Physician 1998; 58(2): 443-50.
[PMID: 9713398]
[110]
Wenban C, Heer RS, Baktash V, et al. Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalized Covid-19 patients. J Med Virol 2021; 93(12): 6605-10.
[http://dx.doi.org/10.1002/jmv.27215 ] [PMID: 34273116]
[111]
Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021; 384(8): 693-704.
[http://dx.doi.org/10.1056/NEJMoa2021436 ] [PMID: 32678530]
[112]
Kumar G, Patel D, Hererra M, et al. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients? J Med Virol 2022; 94(1): 372-9.
[http://dx.doi.org/10.1002/jmv.27357 ] [PMID: 34559436]
[113]
Umbrello M, Formenti P, Nespoli S, Pisano E, Bonino C, Muttini S. Effect of different corticosteroid regimens on the outcome of severe COVID-19-related Acute Respiratory Failure. A Retrospective Analysis. J Clin Med 2021; 10(21): 4847.
[http://dx.doi.org/10.3390/jcm10214847 ] [PMID: 34768369]
[114]
Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA 2020; 324(13): 1330-41.
[http://dx.doi.org/10.1001/jama.2020.17023 ] [PMID: 32876694]
[115]
Slominski RM, Stefan J, Athar M, et al. COVID-19 and vitamin D: A lesson from the skin. Exp Dermatol 2020; 29(9): 885-90.
[http://dx.doi.org/10.1111/exd.14170 ] [PMID: 32779213]
[116]
Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J Immunol 1986; 136(8): 2734-40.
[PMID: 3007606]
[117]
Ismailova A, White JH, Vitamin D. Vitamin D, infections and immunity. Rev Endocr Metab Disord 2021; 1-13.
[PMID: 34322844]
[118]
Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014; 7: 69-87.
[PMID: 24971027]
[119]
Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311(5768): 1770-3.
[http://dx.doi.org/10.1126/science.1123933 ] [PMID: 16497887]
[120]
Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12(4): E988.
[http://dx.doi.org/10.3390/nu12040988 ] [PMID: 32252338]
[121]
Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009; 158(1): 20-5.
[http://dx.doi.org/10.1111/j.1365-2249.2009.04001.x ] [PMID: 19737226]
[122]
Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134(6): 1129-40.
[http://dx.doi.org/10.1017/S0950268806007175 ] [PMID: 16959053]
[123]
Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis. Health Technol Assess 2019; 23(2): 1-44.
[http://dx.doi.org/10.3310/hta23020 ] [PMID: 30675873]
[124]
Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: A review of molecular mechanisms and clinical studies. Adv Nutr 2011; 2(3): 244-53.
[http://dx.doi.org/10.3945/an.111.000398 ] [PMID: 22332056]
[125]
Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine (Baltimore) 2019; 98(38): e17252.
[http://dx.doi.org/10.1097/MD.0000000000017252 ] [PMID: 31567995]
[126]
Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis 2013; 57(3): 392-7.
[http://dx.doi.org/10.1093/cid/cit289 ] [PMID: 23677871]
[127]
Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, et al. Treatment with 25-hydroxyvitamin D3 (Calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: A pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial. Endocr Pract 2021; 27(12): 1242-51.
[http://dx.doi.org/10.1016/j.eprac.2021.09.016 ] [PMID: 34653608]
[128]
Grant WB, Lordan R. Vitamin D for COVID-19 on trial: An update on prevention and therapeutic application. Endocr Pract 2021; 27(12): 1266-8.
[http://dx.doi.org/10.1016/j.eprac.2021.10.001 ] [PMID: 34648940]
[129]
Coperchini F, Chiovato L, Ricci G, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved. Cytokine Growth Factor Rev 2021; 58: 82-91.
[http://dx.doi.org/10.1016/j.cytogfr.2020.12.005 ] [PMID: 33573850]
[130]
Han JE, Jones JL, Tangpricha V, et al. High dose vitamin D administration in ventilated intensive care unit patients: A pilot double blind randomized controlled trial. J Clin Transl Endocrinol 2016; 4: 59-65.
[http://dx.doi.org/10.1016/j.jcte.2016.04.004 ] [PMID: 27419080]
[131]
Zhang YG, Wu S, Sun J, Vitamin D. receptor, and tissue barriers. Tissue Barriers 2013; 1(1): e23118.
[http://dx.doi.org/10.4161/tisb.23118 ] [PMID: 24358453]
[132]
Getachew B, Tizabi Y. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity. J Med Virol 2021; 93(9): 5285-94.
[http://dx.doi.org/10.1002/jmv.27075 ] [PMID: 33990955]
[133]
Xiao D, Li X, Su X, Mu D, Qu Y. Could SARS-CoV-2-induced lung injury be attenuated by vitamin D? Int J Infect Dis 2021; 102: 196-202.
[http://dx.doi.org/10.1016/j.ijid.2020.10.059 ] [PMID: 33129966]
[134]
Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone. Science 1984; 224(4656): 1438-40.
[http://dx.doi.org/10.1126/science.6427926 ] [PMID: 6427926]
[135]
Fisher SA, Rahimzadeh M, Brierley C, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS One 2019; 14(9): e0222313.
[http://dx.doi.org/10.1371/journal.pone.0222313 ] [PMID: 31550254]
[136]
Prietl B, Treiber G, Mader JK, et al. High-dose cholecalciferol supplementation significantly increases peripheral CD4+ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr 2014; 53(3): 751-9.
[http://dx.doi.org/10.1007/s00394-013-0579-6 ] [PMID: 23999998]
[137]
Bock G, Prietl B, Mader JK, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: A randomized controlled trial. Diabetes Metab Res Rev 2011; 27(8): 942-5.
[http://dx.doi.org/10.1002/dmrr.1276 ] [PMID: 22069289]
[138]
Weir EK, Thenappan T, Bhargava M, Chen Y. Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond) 2020; 20(4): e107-8.
[http://dx.doi.org/10.7861/clinmed.2020-0301 ] [PMID: 32503801]
[139]
Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020; 130(5): 2620-9.
[http://dx.doi.org/10.1172/JCI137244 ] [PMID: 32217835]
[140]
Hariyanto TI, et al. Vitamin D supplementation and COVID‐19 outcomes: A systematic review, meta‐analysis and meta‐regression. Rev Med Virol 2021; 27(10)
[http://dx.doi.org/10.1002/rmv.2269]
[141]
Pal R, Banerjee M, Bhadada SK, Shetty AJ, Singh B, Vyas A. Vitamin D supplementation and clinical outcomes in COVID-19: A systematic review and meta-analysis. J Endocrinol Invest 2021; 1-16.
[PMID: 34165766]
[142]
Murai IH, Fernandes AL, Sales LP, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial. JAMA 2021; 325(11): 1053-60.
[http://dx.doi.org/10.1001/jama.2020.26848 ] [PMID: 33595634]
[143]
da Rocha AP, Atallah AN, Aldrighi JM, Pires ALR, Dos Santos Puga ME, Pinto ACPN. Insufficient evidence for vitamin D use in COVID-19: A rapid systematic review. Int J Clin Pract 2021; 75(11): e14649.
[http://dx.doi.org/10.1111/ijcp.14649 ] [PMID: 34310814]
[144]
Cereda E, Bogliolo L, de Stefano L, Caccialanza R. A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019. Curr Opin Clin Nutr Metab Care 2021; 24(1): 102-7.
[http://dx.doi.org/10.1097/MCO.0000000000000701 ] [PMID: 33003119]
[145]
Boaz M. Vitamin D and COVID-19: Partial evidence. BCHD 2021; 4(3): 40-4.
[146]
Zhang Y, Leung DYM, Goleva E. Vitamin D enhances glucocorticoid action in human monocytes: Involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J Biol Chem 2013; 288(20): 14544-53.
[http://dx.doi.org/10.1074/jbc.M112.427054 ] [PMID: 23572530]
[147]
Ferreira GB, Kleijwegt FS, Waelkens E, et al. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res 2012; 11(2): 941-71.
[http://dx.doi.org/10.1021/pr200724e ] [PMID: 22103328]
[148]
Penna G, Amuchastegui S, Giarratana N, et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007; 178(1): 145-53.
[http://dx.doi.org/10.4049/jimmunol.178.1.145 ] [PMID: 17182549]
[149]
Mehta AA, Agrawal AD, Appanna V, Chaudagar KK. Vitamin D improves corticosteroid efficacy and attenuates its side-effects in an animal model of asthma. Can J Physiol Pharmacol 2015; 93(1): 53-61.
[http://dx.doi.org/10.1139/cjpp-2014-0323 ] [PMID: 25429688]
[150]
Agrawal AD. Evaluation of corticosteroids-vitamin D combination in asthma PhD Thesis, Ahmedabad: Gujarat Technological University 2016.
[151]
Hidalgo AA, Deeb KK, Pike JW, Johnson CS, Trump DL. Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription. J Biol Chem 2011; 286(42): 36228-37.
[http://dx.doi.org/10.1074/jbc.M111.244061 ] [PMID: 21868377]
[152]
Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 2010; 24(1): 128-47.
[http://dx.doi.org/10.1210/me.2009-0140 ] [PMID: 19897601]
[153]
Kurahashi I, Matsunuma A, Kawane T, Abe M, Horiuchi N. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3. Endocrine 2002; 17(2): 109-18.
[http://dx.doi.org/10.1385/ENDO:17:2:109 ] [PMID: 12041912]
[154]
Dhawan P, Christakos S. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: Cooperative effects of the glucocorticoid receptor, C/EBP beta, and the vitamin D receptor in 24(OH)ase transcription. J Cell Biochem 2010; 110(6): 1314-23.
[http://dx.doi.org/10.1002/jcb.22645 ] [PMID: 20564225]
[155]
Garg S, Patel K, Pham H, et al. Clinical trends among U.S. adults hospitalized with COVID-19, march to December 2020: A cross-sectional study. Ann Intern Med 2021; 174(10): 1409-19.
[http://dx.doi.org/10.7326/M21-1991 ] [PMID: 34370517]
[156]
Al-Anouti F, Mousa M, Karras SN, et al. Associations between genetic variants in the vitamin D metabolism pathway and severity of COVID-19 among UAE residents. Nutrients 2021; 13(11): 3680.
[http://dx.doi.org/10.3390/nu13113680 ] [PMID: 34835935 ]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy